|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||14.57 - 15.15|
|52 Week Range||8.92 - 18.39|
|Beta (3Y Monthly)||0.14|
|PE Ratio (TTM)||428.57|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The big shareholder groups in OptimizeRx Corporation (NASDAQ:OPRX) have power over the company. Institutions often own...
The Russell 2000 Index is a small-cap stock market index that includes the bottom 2,000 companies found in the Russell 3000 index. The Russell Microcap Index includes the 1,000 smallest securities found ...
Red Hat's (RHT) first-quarter fiscal 2020 results benefit from strengthening subscription revenues and solid momentum with large deals.
The Zacks Analyst Blog Highlights: Malibu Boats, MEDIFAST, OptimizeRx, Synergy Resources and Pioneer Natural
Open Text (OTEX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights: OptimizeRx, eHealth, Strategic Education, Hibbett Sports and PC-Tel
Powell's statement is in sharp contrast to his aggressive monetary stance in 2018 and a steady monetary policy for 2019, which he reaffirmed last month.
Wall Street bull run, which continued in the first four months of this year and recorded the best start in 30 years, halted in May.
Today we are going to look at OptimizeRx Corporation (NASDAQ:OPRX) to see whether it might be an attractive investment...
Will Febbo has been the CEO of OptimizeRx Corporation (NASDAQ:OPRX) since 2016. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider gro...
OptimizeRx Corp is a technology solutions company serving the healthcare industry. OptimizeRx Corp had annual average EBITDA growth of 23.90% over the past ten years. Warning! GuruFocus has detected 2 Warning Signs with OPRX.
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! While some investors are already well versed in financial metricsRead More...
OptimizeRx Corp., a digital health messaging company, for the pharmaceutical industry, has formed a partnership with Birmingham's IllumiCare. IllumiCare’s Smart Ribbon platform will feature a new app from OptimizeRx that presents drug-savings opportunities that health providers and the clinical care team can distribute to the patient directly at the point-of-care. “Our collaboration with OptimizeRx will enable providers to be better stewards of health care spending,” said G.T. LaBorde, CEO of IllumiCare. “Our Smart Ribbon technology, accessible within the provider’s workflow in the electronic health record (EHR), will give providers easy access to render coupons, savings opportunities or alternate drug choices to best support the patient.” IllumiCare offers a non-intrusive electronic medical record tool that provides clinicians with patient-specific information ranging from real-time costs of procedures to predicted patient harm data.
If you own shares in OptimizeRx Corporation (NASDAQ:OPRX) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of Read More...